NANOPARTICLE COMPOSITION

PROBLEM TO BE SOLVED: To provide a particulate anticancer agent, an anticancer composition including the particulate (nanoparticle) and to provide a method for using the particulate. SOLUTION: The invention provides dispersible particulates consisting substantially of a crystalline anticancer agent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SARPOTDAR PRAMOD P, LIVERSIDGE ELAINE, LIVERSIDGE GARY G
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SARPOTDAR PRAMOD P
LIVERSIDGE ELAINE
LIVERSIDGE GARY G
description PROBLEM TO BE SOLVED: To provide a particulate anticancer agent, an anticancer composition including the particulate (nanoparticle) and to provide a method for using the particulate. SOLUTION: The invention provides dispersible particulates consisting substantially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient for maintaining an effective mean particle size of less than about 1,000 nm. The anticancer composition comprising the particulates exhibits reduced toxicity and/or enhanced efficacy and can be administered by injection. COPYRIGHT: (C)2011,JPO&INPIT
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2010265324A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2010265324A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2010265324A3</originalsourceid><addsrcrecordid>eNrjZJDwc_TzD3AMCvF09nFVcPb3DfAP9gzx9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBoYGRmamxkYmjsZEKQIASiogWQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NANOPARTICLE COMPOSITION</title><source>esp@cenet</source><creator>SARPOTDAR PRAMOD P ; LIVERSIDGE ELAINE ; LIVERSIDGE GARY G</creator><creatorcontrib>SARPOTDAR PRAMOD P ; LIVERSIDGE ELAINE ; LIVERSIDGE GARY G</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a particulate anticancer agent, an anticancer composition including the particulate (nanoparticle) and to provide a method for using the particulate. SOLUTION: The invention provides dispersible particulates consisting substantially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient for maintaining an effective mean particle size of less than about 1,000 nm. The anticancer composition comprising the particulates exhibits reduced toxicity and/or enhanced efficacy and can be administered by injection. COPYRIGHT: (C)2011,JPO&amp;INPIT</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101125&amp;DB=EPODOC&amp;CC=JP&amp;NR=2010265324A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101125&amp;DB=EPODOC&amp;CC=JP&amp;NR=2010265324A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SARPOTDAR PRAMOD P</creatorcontrib><creatorcontrib>LIVERSIDGE ELAINE</creatorcontrib><creatorcontrib>LIVERSIDGE GARY G</creatorcontrib><title>NANOPARTICLE COMPOSITION</title><description>PROBLEM TO BE SOLVED: To provide a particulate anticancer agent, an anticancer composition including the particulate (nanoparticle) and to provide a method for using the particulate. SOLUTION: The invention provides dispersible particulates consisting substantially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient for maintaining an effective mean particle size of less than about 1,000 nm. The anticancer composition comprising the particulates exhibits reduced toxicity and/or enhanced efficacy and can be administered by injection. COPYRIGHT: (C)2011,JPO&amp;INPIT</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDwc_TzD3AMCvF09nFVcPb3DfAP9gzx9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBoYGRmamxkYmjsZEKQIASiogWQ</recordid><startdate>20101125</startdate><enddate>20101125</enddate><creator>SARPOTDAR PRAMOD P</creator><creator>LIVERSIDGE ELAINE</creator><creator>LIVERSIDGE GARY G</creator><scope>EVB</scope></search><sort><creationdate>20101125</creationdate><title>NANOPARTICLE COMPOSITION</title><author>SARPOTDAR PRAMOD P ; LIVERSIDGE ELAINE ; LIVERSIDGE GARY G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2010265324A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SARPOTDAR PRAMOD P</creatorcontrib><creatorcontrib>LIVERSIDGE ELAINE</creatorcontrib><creatorcontrib>LIVERSIDGE GARY G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SARPOTDAR PRAMOD P</au><au>LIVERSIDGE ELAINE</au><au>LIVERSIDGE GARY G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NANOPARTICLE COMPOSITION</title><date>2010-11-25</date><risdate>2010</risdate><abstract>PROBLEM TO BE SOLVED: To provide a particulate anticancer agent, an anticancer composition including the particulate (nanoparticle) and to provide a method for using the particulate. SOLUTION: The invention provides dispersible particulates consisting substantially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient for maintaining an effective mean particle size of less than about 1,000 nm. The anticancer composition comprising the particulates exhibits reduced toxicity and/or enhanced efficacy and can be administered by injection. COPYRIGHT: (C)2011,JPO&amp;INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2010265324A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NANOPARTICLE COMPOSITION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T02%3A30%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SARPOTDAR%20PRAMOD%20P&rft.date=2010-11-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2010265324A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true